Education

Explore how different types of psychological safety help people move from feeling included to confidently contributing to respectfully challenging ideas.

This program reviews urine drug testing for stimulants and phencyclidine (PCP), with an emphasis on the advantages and limitations of traditional immunoassays and targeted mass spectrometry-based screening.

Register now – Dec. 9, 2025 | This webinar will highlight federal and state regulatory updates affecting hospital laboratory outreach programs, including billing, reimbursement, and government enforcement.

REGISTER NOW - This presentation examines how autonomous robotic phlebotomy could transform blood collection. It reviews preanalytic challenges, high-opportunity use cases, clinical findings, and Mayo Clinic human-factors research, with a focus on specimen quality, patient acceptance, workflow, workforce models, and human oversight.

Register now – Jan. 19, 2027 Lessons learned from using audits to drive engagement, strengthen safety culture, increase risk awareness, and support continuous improvement.

Review how problem-solving methods can work together to define and measure a problem, identify root causes, test potential solutions, and sustain successful improvements.

This microlearning reviews myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), with a focus on the 2023 International MOGAD Panel diagnostic criteria.

Join Mayo Clinic Laboratories and C2N Diagnostics for our webinar exploring how the evolution of blood biomarker testing for Alzheimer's disease has expanded access to earlier, less-invasive diagnosis. Focusing on the newly FDA-cleared PrecivityAD2 blood test, which is offered by Mayo Clinic Laboratories in collaboration with C2N Diagnostics, the discussion will highlight how results from blood biomarker testing can support timely diagnosis, informed clinical decision-making, and improved patient care.

Review how to communicate your strengths, share meaningful examples, and ask thoughtful questions that may reveal team culture and expectations.

Join Mayo Clinic Laboratories for our webinar exploring the expanding role of precision diagnostics in the evaluation of serious and potentially life-threatening infections. Focusing on metagenomic sequencing available from Mayo Clinic Laboratories, including the Karius Spectrum plasma test, which is offered by Mayo Clinic Laboratories in collaboration with Karius, participants will gain an overview of microbial cell-free DNA (mcfDNA) metagenomic sequencing, including clinical decision-making around test ordering, appropriate clinical indications, and how to interpret and apply results to support timely diagnosis and patient management.

Explore why traditional microscopy is challenging, how AI-assisted review works, what workflow changes are required, and how validation data can support implementation decisions.

Learn how GFAP testing is emerging as a biomarker to support diagnosis, monitoring, and prognosis in neurological diseases.

Recording coming soon - Review key federal legislative and regulatory developments affecting clinical laboratories.